BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Siramolpiwat S. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications. World J Gastroenterol 2014; 20(45): 16996-17010 [PMID: 25493012 DOI: 10.3748/wjg.v20.i45.16996] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Pereira K, Baker R, Salsamendi J, Doshi M, Kably I, Bhatia S. An Approach to Endovascular and Percutaneous Management of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Dysfunction: A Pictorial Essay and Clinical Practice Algorithm. Cardiovasc Intervent Radiol 2016;39:639-51. [DOI: 10.1007/s00270-015-1247-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
2 Testino G. Hepatorenal syndrome: role of the transjugular intrahepatic stent shunt in real life practice. Clujul Med 2017;90:464-5. [PMID: 29151800 DOI: 10.15386/cjmed-847] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Shah N, Silva RG, Kowalski A, Desai C, Lerma E. Hepatorenal syndrome. Dis Mon. 2016;62:364-375. [PMID: 27372112 DOI: 10.1016/j.disamonth.2016.05.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
4 Li HB, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Dong XQ, Liu FQ. Pathological Features of Mitochondrial Ultrastructure Predict Susceptibility to Post-TIPS Hepatic Encephalopathy. Can J Gastroenterol Hepatol 2018;2018:4671590. [PMID: 30079331 DOI: 10.1155/2018/4671590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
5 Tang S, Zeng W, Qin J, He Q, Wu X, Zhou X, Wang Z, Zeng J, Jin Z, Jiang M. Gastric Variceal Bleeding Caused by an Arterioportal Fistula Formation After TIPS and Related Complications. Dig Dis Sci 2016;61:2442-4. [PMID: 26957496 DOI: 10.1007/s10620-016-4093-6] [Reference Citation Analysis]
6 Shreve L, Lee EW. Role of Interventional Radiology in Complications of Portal Hypertension. Journal of Clinical Gastroenterology 2019;53:342-9. [DOI: 10.1097/mcg.0000000000001180] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 de la Pinta C, Fernández Lizarbe E, Montero Luis Á, Domínguez Rullán JA, Sancho García S. Treatment of symptomatic splenomegaly with low doses of radiotherapy: Retrospective analysis and review of the literature. Tech Innov Patient Support Radiat Oncol 2017;3-4:23-9. [PMID: 32095563 DOI: 10.1016/j.tipsro.2017.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Nicoară-Farcău O, Rusu I, Stefănescu H, Tanțău M, Badea RI, Procopeț B. Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease. World J Gastroenterol 2020; 26(22): 3000-3011 [PMID: 32587444 DOI: 10.3748/wjg.v26.i22.3000] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 de Andres Olabarria U, Ugarte Sierra S, Maniega Alba R, Alberdi San Roman I, Ibáñez Aguirre FJ. Miotomía laparoscópica tras derivación portosistémica intrahepática transyugular y embolización de varices gastroesofágicas en paciente con acalasia y cirrosis. Cirugía Española 2017;95:296-7. [DOI: 10.1016/j.ciresp.2016.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Lee BT, Yang AH, Urban S, Kim KY, Ter-Oganesyan R, Yuan L, Han HH, Khemichian S, Kahn JA, Kim B. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures. Eur J Gastroenterol Hepatol 2021;33:541-6. [PMID: 32398491 DOI: 10.1097/MEG.0000000000001760] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wang S, Xiao M, Hua L, Jia Y, Chen S, Zhang K. Endoscopic therapy for gastro-oesophageal varices of Caroli's syndrome: a case report. J Int Med Res 2020;48:300060519877993. [PMID: 31594447 DOI: 10.1177/0300060519877993] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
12 Huang Z, Yao Q, Zhu J, He Y, Chen Y, Wu F, Hua T. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) created using covered stents of different diameters: A systematic review and meta-analysis. Diagn Interv Imaging 2021;102:279-85. [PMID: 33303394 DOI: 10.1016/j.diii.2020.11.004] [Reference Citation Analysis]
13 Duong N, Healey M, Patel K, Strife BJ, Sterling RK. Use of doppler ultrasound to predict need for transjugular intrahepatic portosystemic shunt revision. World J Hepatol 2022; 14(6): 1200-1209 [DOI: 10.4254/wjh.v14.i6.1200] [Reference Citation Analysis]
14 Patel F, Bick B. Biliary Obstruction After Transjugular Intrahepatic Portosystemic Shunt Placement. ACG Case Rep J 2021;8:e00618. [PMID: 34169113 DOI: 10.14309/crj.0000000000000618] [Reference Citation Analysis]
15 Toshikuni N, Takuma Y, Tsutsumi M. Management of gastroesophageal varices in cirrhotic patients: current status and future directions. Ann Hepatol 2016;15:314-25. [PMID: 27049485 DOI: 10.5604/16652681.1198800] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
16 Feder S, Haberl EM, Spirk M, Weiss TS, Wiest R, Buechler C. Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients. Clin Exp Med 2020;20:289-97. [PMID: 32078718 DOI: 10.1007/s10238-020-00617-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Liu G, Wang X, Yang T, Yan Y, Xiang T, Yang L, Luo X. High Interleukin-8 Levels Associated With Decreased Survival in Patients With Cirrhosis Following Transjugular Intrahepatic Portosystemic Shunt. Front Med 2022;9:829245. [DOI: 10.3389/fmed.2022.829245] [Reference Citation Analysis]
18 Li Y, Liu Z, Liu C. Efficacy and safety of laparoscopic splenectomy for hypersplenism secondary to portal hypertension after transjugular intrahepatic portosystemic shunt. BMC Gastroenterol 2021;21:61. [PMID: 33573590 DOI: 10.1186/s12876-021-01647-2] [Reference Citation Analysis]
19 Ali SM, Wu S, Xu H, Liu H, Hao J, Qin C. A Prospective Study of Endoscopic Injection Sclerotherapy and Endoscopic Variceal Ligation in the Treatment of Esophageal Varices. J Laparoendosc Adv Surg Tech A. 2017;27:333-341. [PMID: 28221819 DOI: 10.1089/lap.2016.0436] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
20 Bisht RU, Liu MC, Koblinski JE, Kang P, Wong MN, Little EC. Is 70 the new 50? Complications and outcomes of transjugular intrahepatic portosystemic shunt in older versus younger patients. Abdom Radiol (NY) 2021;46:2789-94. [PMID: 32296899 DOI: 10.1007/s00261-020-02533-3] [Reference Citation Analysis]
21 Trivedi PS, Brown MA, Rochon PJ, Ryu RK, Johnson DT. Gender Disparity in Inpatient Mortality After Transjugular Intrahepatic Portosystemic Shunt Creation in Patients Admitted With Hepatorenal Syndrome: A Nationwide Study. Journal of the American College of Radiology 2020;17:231-7. [DOI: 10.1016/j.jacr.2019.08.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 He F, Dai S, Xiao Z, Wang L, Yue Z, Zhao H, Zhao M, Lin Q, Dong X, Liu F. Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt. Biomed Res Int 2016;2016:3681731. [PMID: 27975051 DOI: 10.1155/2016/3681731] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
23 Wiest R, Weiss TS, Danielyan L, Buechler C. Serum Amyloid Beta42 Is Not Eliminated by the Cirrhotic Liver: A Pilot Study. J Clin Med 2021;10:2669. [PMID: 34204545 DOI: 10.3390/jcm10122669] [Reference Citation Analysis]
24 Grilo-Bensusan I, Pascasio-Acevedo JM. Hepatopulmonary syndrome: What we know and what we would like to know. World J Gastroenterol 2016; 22(25): 5728-5741 [PMID: 27433086 DOI: 10.3748/wjg.v22.i25.5728] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
25 Teng D, Zuo H, Liu L, Dong J, Ding L. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment. Virol J. 2018;15:151. [PMID: 30285813 DOI: 10.1186/s12985-018-1067-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
26 Perry BC, Kwan SW. Portosystemic Shunts: Stable Utilization and Improved Outcomes, Two Decades After the Transjugular Intrahepatic Portosystemic Shunt. J Am Coll Radiol 2015;12:1427-33. [PMID: 26410348 DOI: 10.1016/j.jacr.2015.06.037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
27 Gjeorgjievski M, Cappell MS. Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy. World J Hepatol 2016; 8(4): 231-262 [PMID: 26855694 DOI: 10.4254/wjh.v8.i4.231] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 6.2] [Reference Citation Analysis]
28 Yang XY, Sun CY, Yuan X, Cui XS. Comparison of efficacy of terlipressin and somatostatin in treatment of hepatogenic diarrhea. Shijie Huaren Xiaohua Zazhi 2015; 23(34): 5539-5543 [DOI: 10.11569/wcjd.v23.i34.5539] [Reference Citation Analysis]
29 Cui PJ, Yao J, Zhu Y, Zhang ZY, Yang J. Effects of a Long-Acting Formulation of Octreotide on Patients with Portal Hypertension. Gastroenterol Res Pract 2017;2017:3943210. [PMID: 28855918 DOI: 10.1155/2017/3943210] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
30 Zhang Z, Chen X, Li C, Feng H, Yu H, Zhu R, Wang T. Safety and Efficacy of a Novel Shunt Surgery Combined with Foam Sclerotherapy of Varices for Prehepatic Portal Hypertension: A Pilot Study. Clinics (Sao Paulo) 2019;74:e704. [PMID: 31433045 DOI: 10.6061/clinics/2019/e704] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]